Physician

Aditya Bagrodia, MD

According to 2025 Medicare claims, Aditya Bagrodia, MD (NPI: 1730310665) practices urology in the San Diego-Chula Vista-Carlsbad, CA market, with the plurality of this provider's patient population coming from San Diego, CA. This provider's primary affiliated billing organization is REGENTS OF THE UNIVERSITY OF CALIFORNIA (NPI: 1740382993; TIN: 237064656) and primary practice location at 92037-1300.

Bagrodia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 306 traditional Medicare patients, billed 841 HCPCS/CPT codes, and received $117,153 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 329 prescription claims across 143 beneficiaries totaling $88,959 in drug costs, led by Orgovyx (Relugolix). DME data shows 120 claims. Open Payments data shows 35 records totaling $25,900. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $695 to $88,959. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $681 and ending at $402.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	31	46	$3,208
2016	58	113	$23,075
2017	194	967	$123,029
2018	253	815	$156,917
2019	258	1,557	$165,270
2020	250	2,439	$147,362
2021	326	1,589	$121,921
2022	264	706	$98,758
2023	284	774	$111,252
2024	306	841	$117,153

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	33	52	$695
2016	37	77	$3,174
2017	64	159	$6,117
2018	92	222	$6,305
2019	118	276	$11,365
2020	97	241	$14,773
2021	117	294	$18,282
2022	122	341	$26,447
2023	147	404	$92,060
2024	143	329	$88,959

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	122	$9,655
2019	22	197	$20,506
2020	N/R	126	$16,145
2021	26	171	$15,026
2022	26	183	$17,294
2023	N/R	118	$10,610
2024	33	120	$12,941

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	51	51	$147
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	101	120	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	128	163	$87
52000	Diagnostic exam of bladder and urethra using an endoscope	73	112	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	82	88	$52

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Orgovyx	Relugolix	23	720	$63,525
Myrbetriq	Mirabegron	26	1,020	$14,959
Tamsulosin Hcl	Tamsulosin Hcl	81	6,750	$1,593
Finasteride	Finasteride	41	3,676	$658
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	134	$46

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4385	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each	N	11	22	$4,741
A4409	Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each	N	N/R	17	$3,918
A4432	Ostomy pouch, urinary; for use on barrier with non-locking flange, with faucet-type tap with valve (2 piece), each	N	N/R	18	$2,952
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	N	11	25	$846
A5120	Skin barrier, wipes or swabs, each	N	11	24	$256

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	35	$25,900	Ferring Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aditya Bagrodia, MD?

Tedicare shows public-source Medicare data for Aditya Bagrodia, MD (NPI 1730310665), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aditya Bagrodia, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aditya Bagrodia, MD?

Aditya Bagrodia, MD is linked to REGENTS OF THE UNIVERSITY OF CALIFORNIA (billing NPI 1740382993) in the available physician profile data.

Does Aditya Bagrodia, MD have Open Payments data?

Aditya Bagrodia, MD has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.